Clinical trials
Recruiting Phase 1/2 Carcinoma, Merkel Cell trials
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
10 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2021 | 1 |
| 2022 | 2 |
| 2023 | 2 |
| 2024 | 1 |
| 2025 | 2 |
| 2026 | 2 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Recruiting | 10 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Arvinas Inc. | 1 |
| AstraZeneca | 1 |
| Aulos Bioscience, Inc. | 1 |
| Marengo Therapeutics, Inc. | 1 |
| Mayo Clinic | 1 |
| Medicenna Therapeutics, Inc. | 1 |
| Merck Sharp & Dohme LLC | 1 |
| National Cancer Institute (NCI) | 1 |
| Neonc Technologies, Inc. | 1 |
| University of Arizona | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Carcinoma, Merkel Cell | 10 |
| Melanoma | 9 |
| Carcinoma, Non-Small-Cell Lung | 7 |
| Carcinoma, Renal Cell | 6 |
| Stomach Neoplasms | 6 |
| Uterine Cervical Neoplasms | 6 |
| Squamous Cell Carcinoma of Head and Neck | 5 |
| Colorectal Neoplasms | 4 |
| Esophageal Neoplasms | 4 |
| Triple Negative Breast Neoplasms | 4 |
Trials
Showing 1 to 10 of 10. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.